Galecto Inc (GLTO)
5.62
-0.22
(-3.85%)
USD |
NASDAQ |
Nov 22, 16:00
5.60
-0.02
(-0.36%)
After-Hours: 20:00
Galecto Total Liabilities (Quarterly): 2.441M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.441M |
| June 30, 2024 | 3.709M |
| March 31, 2024 | 4.318M |
| December 31, 2023 | 5.896M |
| September 30, 2023 | 12.67M |
| June 30, 2023 | 15.10M |
| March 31, 2023 | 14.30M |
| December 31, 2022 | 11.44M |
| September 30, 2022 | 9.298M |
| June 30, 2022 | 7.793M |
| Date | Value |
|---|---|
| March 31, 2022 | 7.616M |
| December 31, 2021 | 4.992M |
| September 30, 2021 | 6.254M |
| June 30, 2021 | 5.39M |
| March 31, 2021 | 6.084M |
| December 31, 2020 | 6.107M |
| September 30, 2020 | 8.87M |
| June 30, 2020 | 3.894M |
| December 31, 2019 | 8.138M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.441M
Minimum
Sep 2024
15.10M
Maximum
Jun 2023
7.595M
Average
6.254M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk AS | 41.48B |
| Genmab AS | 1.159B |
| Ascendis Pharma AS | 1.330B |
| Evaxion Biotech AS | 15.18M |
| IO Biotech Inc | 17.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.38M |
| Shareholders Equity (Quarterly) | 20.94M |